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The CD19/CD21 Complex Functions
to Prolong B Cell Antigen Receptor
Signaling from Lipid Rafts
strated to regulate the function of the Src family kinase
Lyn by a novel mechanism that involves the amplifica-
tion of Lyn activation (Fujimoto et al., 2000). The impor-
tance of CD19 as a coreceptor for the BCR in vivo has
been demonstrated by the phenotype of mice that lack
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CD19, which show reduced primary antibody responsesNational Institutes of Health
and germinal center formation in response to T cell–Rockville, Maryland 20852
dependent antigens (Engel et al., 1995; Rickert et al.,†Department of Biochemistry,
1995; Fehr et al., 1998). Conversely, mice that overex-Molecular Biology, and Cell Biology
press CD19 show significantly augmented responses toNorthwestern University
T cell–dependent antigens (Engel et al., 1995; Sato etEvanston, Illinois 60208
al., 1995).
CD19 is expressed on the B cell surface as a noncova-
lent complex with CD21 (the complement receptor orSummary
CR2), CD81 (TAPA-1), and Leu-13 (reviewed in Fearon
and Carroll, 2000). Through the binding of C3d-taggedThe CD19/CD21 complex functions to significantly en-
antigens, CD21 functions to coligate the BCR and CD19,hance B cell antigen receptor (BCR) signaling in re-
resulting in significant augmentation of B cell responses.sponse to complement-tagged antigens. Recent stud-
Indeed, a recombinant antigen that contained three tan-ies showed that following antigen binding the BCR
demly arranged copies of C3d and the antigen hen eggtranslocates into plasma membrane lipid rafts that
lysozyme (HEL-C3d) were shown to be highly immuno-serve as platforms for BCR signaling. Here, we show
genic in vivo, inducing maximal antibody responses atthat the binding of complement-tagged antigens stim-
1/1000 the antigen concentration required for unmodi-ulates the translocation of both the BCR and the CD19/
fied antigens (Dempsey et al., 1996). As shown for CD19,CD21 complex into lipid rafts, resulting in prolonged
coligation of the BCR and the CD19/CD21 complex re-residency in and signaling from the rafts, as compared
sults in enhanced release of intracellular Ca21 (Carterto BCR cross-linking alone. When coligated to the
et al., 1991; Dempsey et al., 1996), induction of DNABCR, the CD19/CD21 complex retards the internaliza-
synthesis (Carter and Fearon, 1992), and antibody pro-tion and degradation of the BCR. The colocalization
duction (Callard et al., 1992). Evidence for a role for CD21and stabilization of the BCR and the CD19/CD21 com-
and complement in the induction of B cell responses inplex in plasma membrane lipid rafts represents a novel
vivo is provided by CD21-deficient mice that show poormechanism by which a coreceptor enhances BCR sig-
primary and secondary antibody responses to T cell–naling.
dependent antigens (Ahearn et al., 1996; Molina et al.,
1996). Similarly, mice deficient in the C3 or C4 compo-Introduction
nent of complement show severely impaired IgG anti-
body responses to T cell–dependent antigens (FischerThe CD19/CD21 complex plays a critical role in B cell
et al., 1996). Both B cells and follicular dendritic cellsresponses to T cell–dependent antigens. CD19 is an
(FDC) express CD21, and the evidence at present indi-essential coreceptor for the B cell antigen receptor
cates that the expression of CD21 by B cells is necessary(BCR) and functions to synergistically enhance signaling
for antibody responses to T cell–dependent antigens
through the BCR, thus reducing the threshold for B cell
(Ahearn et al., 1996; Croix et al., 1996).
activation (reviewed in Tedder et al., 1997). Studies in
Recent evidence indicates that following antigen
vitro show that CD19 signals independently of the BCR, binding the BCR rapidly translocates into cholesterol-
but coligation of the BCR and CD19 results in synergistic and sphingolipid-rich membrane microdomains termed
signaling, the net result of which is a reduction in the lipid rafts (Cheng et al., 1999). The lipid rafts concentrate
degree of ligation of the BCR required for full B cell the Src family protein tyrosine kinase Lyn, which plays
activation (Carter and Fearon, 1992). Recent evidence a key role in the induction of BCR signaling and exclude
indicates that CD19 functions as a specialized mem- the phosphatase CD45. Following cross-linking, both
brane adaptor protein for the BCR, recruiting Vav and Iga and Lyn in rafts are phosphorylated. Subsequently,
phosphatidylinositol 3-kinase (Tuveson et al., 1993), re- the BCR is internalized from the lipid rafts into the cell—a
sulting in the generation of inositol-1,4,5-trisphosphate process that plays a role both in the targeting of antigens
and elevation of intracellular Ca21 concentrations (O’Rourke for presentation and in the downregulation of BCR sig-
et al., 1998). Ligation of CD19 or coligation of the BCR naling. Thus, lipid rafts appear to function as platforms
and CD19 also results in activation of three mitogen- for the induction and regulation of BCR signaling cas-
activated protein kinases, ERK2, JNK, and p38 (Weng cades.
et al., 1994; Tooze et al., 1997; Li and Carter, 1998; Here, we explore the role of the CD19/CD21 complex
O’Rourke et al., 1998). Recently, CD19 was demon- in the translocation of the BCR into lipid rafts following
coligation by complement-tagged antigens using the
potent in vivo immunogen HEL-C3d, described above.‡ To whom correspondence should be addressed (e-mail: spierce@
niaid.nih.gov). We find that the CD19/CD21 complex significantly sus-
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Figure 1. Antigens that Engage the BCR and the CD19/CD21 Complex
Depicted are the antigens used to assess the effect of the CD19/CD21 complex on BCR translocation into lipid rafts. For PC-specific CH27
cells, PC-HEL cross-links the BCR, PC-HEL-C3d coligates the BCR to the CD19/CD21 complex, and HEL-C3d cross-links the CD19/CD21
complex. For anti-HEL-Tg B cells, HEL engages the BCR, and HEL-C3d coligates the BCR and the CD19/CD21 complex.
tains BCR residency in lipid rafts, resulting in prolonged 48C for 30 min without antigen or with PC-HEL, HEL-
C3d, or PC-HEL-C3d. Following incubation, the cellsBCR signaling—a function that may contribute to CD19/
were washed, lysed at 48C in buffer containing 1% TritonCD21 enhancement of B cell responses.
X-100, a detergent in which the lipid rafts are insoluble,
and subjected to sucrose density gradient centrifuga-Results
tion. Fractions from the gradient were collected and
analyzed for the presence of CD19, CD21, and the BCR.The Effect of the CD19/CD21 Complex
To detect CD19, fractions were immunoprecipitated us-
on Translocation of the BCR into Lipid Rafts
ing a CD19-specific mAb and the immunoprecipitates
The CD19/CD21 complex plays an important role in aug-
subjected to SDS-PAGE and immunoblotting, probing
menting BCR signaling to complement-tagged antigens. with streptavidin to detect biotinylated proteins. For
Given that an initial step in BCR signaling involves the CD21 and the BCR, gradient fractions were subjected
rapid translocation of the BCR into lipid rafts (Cheng et to SDS-PAGE and immunoblotting, probing for CD21,
al., 1999), it was of interest to determine if the CD19/ using a CD21-specific mAb; Ig H chain, using goat anti-
CD21 complex also functions from within lipid rafts. The bodies specific for mouse m chain; or Iga, using rabbit
position of the CD19/CD21 complex in the plasma mem- antibodies specific for Iga.
brane of B cells was analyzed in untreated cells or cells To verify the position of the Triton X-100-insoluble
treated to coligate the CD19/CD21 complex to the BCR lipid rafts in the sucrose gradients, the gradient fractions
or cross-link the CD19/CD21 complex to itself using were assayed for the sphingolipid GM1, the Src family
CH27 cells and the antigens depicted in Figure 1. CH27 tyrosine kinase Lyn, and actin, each previously shown
cells that express a phosphorylcholine (PC)-specific to reside in lipid rafts in B cells, and CD45R, which is
BCR were incubated with PC coupled to HEL (PC-HEL), excluded from B cell lipid rafts (Cheng et al., 1999).
the recombinant C3d-containing antigen (HEL-C3d), or Fractions 4–6 of the discontinuous sucrose gradient,
PC coupled to HEL-C3d (PC-HEL-C3d). SDS-PAGE which contain the interface of the 5% and 15% sucrose
analysis of the antigens indicates that the recombinant solutions where membranes float, contained GM1, Lyn,
HEL-C3d protein is of the predicted size to contain HEL and actin (Figure 2B). CD45R was excluded from the
and all three copies of C3d encoded in the construct Triton X-100-insoluble lipid rafts and was present only
(Figure 2A). The PC-HEL preparation appears to contain in the soluble membrane fractions (fractions 11 and 12).
monomers of HEL as well as higher molecular weight Material is also variably detected in fractions 9 and 10
oligomers. PC-HEL cross-links the BCR on CH27 cells, and may represent variability in the solubilization of
unmodified HEL-C3d cross-links the CD19/CD21 com- membranes altering the buoyancy of the material in the
plex to itself, and PC-HEL-C3d coligates the CD19/CD21 gradient. However, the presence of proteins in these
complex to the BCR. fractions has not been correlated to any one factor. The
CH27 cells were surface biotinylated to allow the de- position of GM1, Lyn, actin, and CD45R in the B cell
plasma membrane was not affected by the incubationtection of plasma membrane proteins and incubated at
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Figure 2. The CD19/CD21 Complex Translocates into Lipid Rafts upon Ligation
CH27 cells were surface biotinylated and incubated either alone or with PC-HEL, HEL-C3d, or PC-HEL-C3d for 30 min at 48C. The cells were
lysed in Triton X-100 and the lysates subjected to sucrose density gradient centrifugation. Gradient fractions (1 ml) were collected and either
analyzed separately or pooled into pairs.
(A) SDS-PAGE and immunoblot analysis of the antigens HEL-C3d, PC-HEL, and HEL, using the HEL-specific mAb HyHEL 10.
(B) Sucrose gradient fractions were analyzed by SDS-PAGE, followed by immunoblotting for GM1, Lyn, CD45R, and actin.
(C) Sucrose gradient fractions were immunoprecipitated using an anti-CD19 mAb, followed by SDS-PAGE and streptavidin blotting, or
immunoblotted for CD21, Ig m chain (Ig H), and Iga.
of B cells with the antigens described above (data not tions (Figure 2C). The position of the BCR was not dra-
matically affected by cross-linking CD19/CD21 to itself,shown).
In untreated cells, both CD19 and CD21 resided in although there appeared to be a slight increase in the
quantity of BCR stably present in the rafts. Significantly,the Triton X-100-soluble fractions (11 and 12), indicating
that the CD19/CD21 complex was not constitutively the coligation of the CD19/CD21 complex and the BCR
using PC-HEL-C3d resulted in the translocation of thepresent in lipid rafts (Figure 2C). CD19/CD21 are also
variably detected in fraction 9 and 10. Cross-linking the BCR into the lipid rafts. The coligation of the BCR and
the CD19/CD21 complex appears to result in a moreBCR using PC-HEL had no effect on the location of the
CD19/CD21 complex. However, cross-linking the CD19/ complete and stable retention of Iga in the rafts as com-
pared to the surface Ig, suggesting that there may beCD21 complex to itself using HEL-C3d resulted in the
near complete translocation of CD19 and CD21 into the a temporary destabilization of the BCR in the rafts upon
coligation with the CD19/CD21 complex. Thus, thelipid rafts. The cotranslocation of both CD19 and CD21
into rafts following engagement of CD21 with its ligand CD19/CD21 complex and the BCR appeared to behave
independently on the B cell plasma membrane but trans-C3d indicates that CD19 and CD21 are stably associated
in the plasma membrane or become associated follow- locate together into lipid rafts when coligated.
The integrity of the lipid rafts is dependent on theing ligand binding. Coligating the CD19/CD21 complex
and the BCR using PC-HEL-C3d also resulted in the presence of cholesterol (Harder et al., 1997). To verify
that the presence of the CD19/CD21 complex in the lipidcomplete translocation of CD19 and CD21 into lipid
rafts. Thus, the engagement of the CD19/CD21 complex raft region of the sucrose gradient does indeed depend
on cholesterol, cells were treated with the cholesterol-alone or with the BCR induced its translocation into lipid
rafts. sequestering drug methyl-b-cyclodextrin (MCD), which
results in the dispersion of the cholesterol-rich lipid raftsThe BCR is excluded from lipid rafts in untreated B
cells (Figure 2C). Cross-linking the BCR using PC-HEL (Harder et al., 1997; Cheng et al., 1999). CH27 cells were
treated with PC-HEL-C3d to coligate the CD19/CD21resulted in the translocation of the BCR into lipid rafts
but had no effect on the location of the CD19/CD21 complex and the BCR and then treated for 20 min with
MCD to deplete cholesterol, washed, and cultured incomplex, which remained in the soluble membrane frac-
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Figure 3. CD19/CD21 Translocation into Rafts
Is Cholesterol Dependent
CH27 cells were surface biotinylated and
treated with 12.5 mM MCD in the presence
or absence of the antigen PC-HEL-C3d for 20
min at 378C. At the end of the treatment, the
cells were either immediately lysed in Triton
X-100 or allowed to recover for 3 hr in 15%
CM containing cholesterol before lysis. Ly-
sates were subjected to sucrose density gra-
dient centrifugation and the gradient frac-
tions analyzed by immunoprecipitation for
CD19, followed by SDS-PAGE and streptavidin
blotting or by SDS-PAGE and immunoblotting
for CD21 using a CD21-specific mAb.
the presence of cholesterol. The CD19/CD21 complex of both Ig and Iga into rafts appears nearly complete at
15 min, as compared to the translocation of Ig and Igathat translocated into the lipid rafts upon binding of PC-
HEL-C3d dispersed into the soluble membrane fractions induced by BCR cross-linking alone, in which case a
smaller fraction of the BCR translocated into rafts. Asfollowing MCD treatment (Figure 3). Upon cholesterol
recovery for 3 hr at 378C, the CD19/CD21 complex was noted above, at 30 min, nearly all Iga still resides in
rafts, while a portion of Ig appears in the soluble fraction.again found in lipid rafts. Thus, the presence of the
CD19/CD21 complex in the Triton X-100 detergent-insol- By 45 min, the distribution of Ig and Iga in the soluble
and raft fractions appears similar. Thus, the coligationuble fractions was dependent on the presence of choles-
terol in the plasma membranes. of the BCR and the CD19/CD21 complex results in a
more complete translocation of the BCR into lipid rafts
accompanied by a brief destablization of the BCR in theColigation of the BCR and the CD19/CD21 Complex
rafts and prolonged residency.Prolongs Retention of the BCR in Lipid Rafts
The time course of translocation of the CD19/CD21 com-
plex and the BCR into lipid rafts following incubation Coligation of the BCR and CD19/CD21 Complex
Prolongs Signaling from the Lipid Raftswith PC-HEL to cross-link the BCR or with PC-HEL-C3d
to coligate the BCR and the CD19/CD21 complex was Our previous studies showed that BCR cross-linking
resulted in the tyrosine phosphorylation of a number ofdetermined. The BCR translocated into lipid rafts imme-
diately following cross-linking with PC-HEL and by 30 raft-associated proteins, including Iga and Lyn (Cheng
et al., 1999). The observation that binding of PC-HEL-min was no longer detectable in the rafts (Figure 4).
Cross-linking the BCR had no effect on the location of C3d prolonged BCR residency in rafts suggested that
BCR signaling from rafts may be prolonged. To test this,the CD19/CD21 complex over the time course of the
experiment. Cross-linking the CD19/CD21 complex to the raft and soluble membrane fractions obtained from
either untreated cells or cells treated to cross-link theitself using HEL-C3d resulted in CD19/CD21 transloca-
tion into rafts at 15 min, which was no longer in the rafts BCR or coligate the BCR and the CD19/CD21 complex
were assayed for the presence of tyrosine-phosphory-at 60 min following cross-linking (Figure 4). CH27 cells
were also incubated with C3dg, a precursor of C3d, lated proteins, including CD19, Iga, and Lyn. As an addi-
tional measure of signaling activity, the position in thewhich binds as a monomer to CD21 with high affinity
and to CD35, albeit with lower affinity (Prodinger et al., gradient fractions of Vav (reviewed in Bustelo, 2000) that
plays a role in the signaling cascades of both the BCR1998). C3dg binding had no effect on the position of the
CD19/CD21 complex or BCR, both of which remained and the CD19/CD21 complex was determined. Cells
were biotinylated to label surface proteins, incubatedin the soluble membrane fractions, as shown at 15 and
60 min following treatment (Figure 4). Thus, transloca- at 48C without antigen or with PC-HEL or PC-HEL-C3d
for 30 min, washed, and warmed to 378C for 0, 30, ortion of the CD19/CD21 complex into lipid rafts appears
to require multivalent binding and cross-linking of the 60 min. The raft and soluble fractions were isolated and
assayed for the presence of tyrosine-phosphorylated pro-complex.
Both CD19 and CD21 were present in the lipid rafts teins. To detect tyrosine-phosphorylated CD19, CD19 was
immunoprecipitated from gradient fractions and the im-immediately following coligation of the BCR and the
CD19/CD21 complex using PC-HEL-C3d and remained munoprecipitates analyzed by SDS-PAGE and immu-
noblotting probing with a phosphotyrosine-specificin the lipid rafts for 15–45 min before returning to the
soluble membrane regions by 60 min following coliga- mAb. Phosphorylated Lyn and Iga were detected in
strepavidin immunoprecipitates of gradient fractions an-tion (Figure 4). Significantly, coligating the BCR to the
CD19/CD21 complex resulted in prolonged residency alyzed by SDS-PAGE and immunoblotting probing se-
quentially for tyrosine-phosphorylated proteins, using aof the BCR in lipid rafts. Following cross-linking and
translocation using PC-HEL, the BCR remained in lipid phosphotyrosine-specific mAb, and for either Lyn or Iga,
using Lyn- or Iga-specific antibodies. Vav was detectedrafts for z15 min. In contrast, following BCR and CD19/
CD21 coligation using PC-HEL-C3d, the BCR was still in gradient fractions subjected to SDS-PAGE and immu-
noblotting probing with Vav-specific antibodies.detected in lipid rafts at 60 min (Figure 4). Thus, coliga-
tion of the BCR to the CD19/CD21 complex resulted in In untreated cells, there was a low constitutive level
of phosphorylated proteins in the soluble fraction andthe retention of the BCR in lipid rafts. The translocation
Lipid Rafts in CD19/CD21 Function
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Figure 4. Coligation of the CD19/CD21 Complex to the BCR Results in Prolonged Retention of the BCR in Plasma Membrane Lipid Rafts
CH27 cells were surface biotinylated and incubated with PC-HEL, PC-HEL-C3d, HEL-C3d, or C3d at 48C for 30 min, washed, and warmed to
378C for 15, 30, 45, or 60 min. The cells were lysed in Triton X-100, the lysates subjected to sucrose density gradient centrifugation, and the
fractions analyzed by immunoprecipitation for CD19, followed by SDS-PAGE and streptavidin blotting or by SDS-PAGE and immunoblotting
for CD21, Ig H, and Iga.
very little phosphorylation of raft proteins (Figure 5). The the entirety of the phosphorylated CD19 resides in lipid
rafts. By 30 min, a portion of phosphorylated CD19 isidentity of one predominant tyrosine-phosphorylated
protein of 140 kDa in the soluble fraction is not known. found outside the rafts, and, by 60 min, phosphorylated
CD19 has exited the rafts and resides in the solubleCD19 is present in the soluble fractions of untreated
cells, as shown above, and there is no detectable tyro- fraction. The coligation of the BCR and the CD19/CD21
complex results in the association of Vav with the lipidsine phosphorylation of the protein. Vav appears to be
present exclusively in the soluble fractions of the unacti- rafts. Vav translocation into rafts occurs immediately
and persists for 30 min. Therefore, the recruitment ofvated cells. Following incubation with PC-HEL to cross-
link the BCR, phosphorylated proteins, including Lyn Vav to the lipid rafts appears dependent on CD19 trans-
location into rafts. Thus, the coligation of the BCR andand Iga, are detected immediately in the rafts (Figure
5). In addition, there are a large number of tyrosine- the CD19/CD21 complex prolongs signaling activity
from within the lipid rafts, as evidenced by the prolongedphosphorylated proteins in the soluble region. The level
of phosphorylated proteins in rafts decreased rapidly, phosphorylation of Iga, Lyn, and CD19 in the lipid rafts
and the association of Vav with the lipid rafts.such that by 60 min the raft pattern resembles that of
untreated cells. BCR cross-linking results in phosphory-
lation of CD19 outside lipid rafts that is evident up to Independent Cross-Linking of the BCR
and of the CD19/CD21 Complex30 min. Vav does not translocate into lipid rafts following
BCR cross-linking. In contrast, phosphorylation of raft Influences Raft Residency and Signaling
The ability of the CD19/CD21 complex to influence theproteins, primarily Iga and Lyn, persisted up to 60 min
in PC-HEL-C3d-treated cells. Following coligation to the signaling and residency of the BCR in the lipid rafts when
coligated to the BCR raises the question as to whetherBCR, CD19 becomes immediately phosphorylated, and
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coligation is necessary for the effect. Alternatively, the significant percent of the antibody was degraded into
TCA-soluble material and released. Significantly, theCD19/CD21 complex when cross-linked and translocated
into rafts may influence the behavior of the BCR that coligation of the BCR to the CD19/CD21 complex re-
duced the amount of the BCR internalized from the cellenters the raft following independent cross-linking. The
time course of the translocation of the CD19/CD21 com- surface to the constitutive levels of unligated BCR (Fig-
ure 7). The coligation of the BCR and the CD19/CD21plex and the BCR into rafts following simultaneous, inde-
pendent cross-linking by PC-HEL and HEL-C3d was complex also resulted in a significant reduction in the
degradation of the [125I]Fab anti-Ig (Figure 7).determined and compared in the same experiment to
coligation by PC-HEL-C3d. The results of coligation Similar results were obtained following the internaliza-
tion of the BCR in splenic B cells. B cells were obtainedwere similar to those given in Figure 4, showing the BCR
retained in the rafts at 60 min, and consequently are not from mice expressing the transgenes for an Ig heavy
and light chain encoding an HEL-specific Ig. The B cellsshown here. Independent cross-linking extended the
residency of the BCR in the rafts with the H chain de- were incubated with either HEL to ligate the BCR or HEL-
C3d to coligate the BCR and the CD19/CD21 complextected at 60 min, but the effect was not as profound
as that seen with coligation (Figure 6A). The pattern of (Figure 1). Incubation with HEL resulted in accelerated
and increased internalization of the BCR. Although HELtyrosine-phosphorylated proteins was also compared in
cells treated with PC-HEL-C3d and PC-HEL plus HEL- contains a single antigenic site, the HEL protein prepara-
tion contains aggregates capable of cross-linking theC3d. The results given in Figures 5 and 6 were from
the same experiment and can be directly compared. BCR. Coligation of the BCR and the CD19/CD21 com-
plex reduced the BCR internalization to constitutive lev-Independent cross-linking of the CD19/CD21 complex
resulted in a lower level of phosphotyrosine-containing els (Figure 7).
The physical coligation of the BCR and the CD19/proteins in the soluble regions (Figure 6C) as compared
coligation (Figure 5). The initial induction of phosphoty- CD21 complex appears necessary to tether the BCR on
the surface, as independent cross-linking of the BCRrosine proteins in the rafts is comparable in independent
and coligated conditions, but the phosphotyrosine pro- and the CD19/CD21 complex had little effect on BCR
internalization. The internalization of the BCR followingteins are far more transient following independent liga-
tion, such that by 60 min the pattern resembles that of simultaneous cross-linking of the BCR by PC-HEL and
the CD19/CD21 complex by HEL-C3d in CH27 cells wasuntreated cells. Particularly notable is the persistence
of phosphorylated Iga in the rafts of coligated cells not similar to that following BCR cross-linking alone. The
ability of the CD19/CD21 complex, when coligated topresent in the rafts of independently ligated cells. Thus,
independent cross-linking influenced the BCR signaling the BCR, to prolong signaling and residency in the rafts
beyond what was achieved by independent cross-link-and residency in rafts but not as dramatically as coli-
gation. ing alone may be due in part to the tethering of the
coligated BCR on the surface.
The CD19/CD21 Complex Tethers the Coligated BCR
on the Cell Surface Discussion
Previous results showed that following translocation
into lipid rafts the BCR is rapidly internalized from the The CD19/CD21 complex is an essential coreceptor for
B cell antibody responses to T cell–dependent antigensrafts and targeted to peptide-loading compartments
(Cheng et al., 1999). Recent results indicate that neither (Fearon and Carter, 1995; Tedder et al., 1997). The CD19/
CD21 complex appears to influence BCR signaling byCD19 nor CD21 are measurably internalized or de-
graded, even following cross-linking with HEL-C3d (A. C. functioning as a rheostat, setting thresholds for B cell
activation. The molecular mechanisms underlying theand S. K. P., unpublished data). These results raise the
possibility that coligation of the CD19/CD21 complex to function of the CD19/CD21 complex involve the phos-
phorylation of CD19, which, through the association ofthe BCR influences the internalization of the BCR. To
test this, the BCR was labeled using [125I]Fab anti-Ig and Vav and phosphatidylinositol 39-kinase, results in the
activation of both lipid and protein kinases that lead tothe cells incubated alone or in the presence of PC-HEL
or PC-HEL-C3d at 48C, washed, and warmed to 378C substantial increases in intracellular Ca21 levels (O’Rourke
et al., 1998; Brooks et al., 2000). Fujimoto et al. (2000)for varying lengths of time. At the end of each time point,
the radioactivity in the supernatant was measured and have recently shown that CD19 is phosphorylated by
the Src family kinase Lyn and regulates Lyn’s activitytaken as the released fraction. The released fraction was
treated with TCA to precipitate intact proteins, and the by a novel mechanism that involves progressive amplifi-
cation of Lyn activation.radioactivity in the TCA-soluble fraction is shown (Figure
7). The cells were treated with acid to remove cell sur- The results presented here demonstrate that coliga-
tion of the BCR and the CD19/CD21 complex results inface–bound [125I]Fab anti-Ig, and the radioactivity asso-
ciated with the cells after acid stripping was taken as the translocation of both the BCR and the CD19/CD21
complex into lipid rafts that function as platforms forthe internal fraction (Figure 7). In the absence of cross-
linking, the BCR showed a constitutive level of internal- BCR signaling. We previously showed that the lipid rafts
concentrate Lyn and exclude the phosphatase CD45Rization, reaching z15% over the 60 min (Figure 7). An
analysis of the TCA solubility of the [125I]anti-Ig showed and that following cross-linking both the BCR and Lyn
in the lipid rafts become phosphorylated (Cheng et al.,little degradation following constitutive uptake (Figure
7). Cells treated with PC-HEL to cross-link the BCR inter- 1999). The results presented here suggest that the
CD19/CD21 complex functions to influence BCR signal-nalized more [125I]Fab anti-Ig, reaching z30%, and a
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Figure 5. Coligation of the BCR and the CD19/CD21 Complex Prolongs BCR and CD19 Signaling from the Lipid Rafts
CH27 cells were surface biotinylated and incubated without antigen, with PC-HEL, PC-HEL-C3d (shown here), or PC-HEL plus HEL-C3d
(shown in Figure 6) for 30 min at 48C, washed, and warmed to 378C for 0, 30, or 60 min. Rafts and soluble membrane fractions were isolated,
and CD19 and tyrosine-phosphorylated CD19 were detected by immunoprecipitation with CD19-specific mAb, 1D3, and immunoblotting
probing with streptavidin-conjugated HRP (CD19) or a phosphotyrosine-specific mAb, RC20H (CD19/P-Tyr), respectively. Vav was detected
by immunoblotting gradient fractions with Vav-specific polyclonal antibodies (Vav). Tyrosine-phosphorylated proteins were detected by
immunoprecipitation of biotinylated surface proteins with streptavidin-agarose and immunoblotting probing with RC20H (P-Tyr). To detect
Iga and Lyn, P-Tyr immunoblots were stripped and reprobed for Iga and Lyn using specific antibodies.
ing from within lipid rafts. Significantly, the BCR that is is simply cross-linked to itself. Prolonged residency of
the BCR in rafts resulted in sustained tyrosine phosphor-coligated to the CD19/CD21 complex is retained within
the lipid rafts for considerably longer than the BCR that ylation of proteins within rafts, including Iga, CD19, and
Immunity
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Figure 6. The Effect of Independent Ligation of the BCR and of the CD19/CD21 Complex on Translocation of the Complex into Rafts
CH27 cells were surface biotinylated and incubated with PC-HEL and HEL-C3d for 30 min at 48C, washed, and warmed to 378C for 0, 15, 30,
45, and 60 min as described in Figure 5.
(A) The cells were lysed in Triton X-100, the lysates subjected to sucrose density gradient centrifugation, and the fractions analyzed for CD19,
CD21, Ig H, and Iga as in Figure 4.
(B) Raft and soluble membrane fractions were assayed for tyrosine-phosphorylated CD19 as in Figure 5.
(C) Gradient fractions were analyzed for the presence of tyrosine-phosphorylated proteins and stripped and reprobed for Iga and Lyn as in
Figure 5.
Lyn. In addition, Vav becomes stably associated with independently of the BCR may be necessary to mediate
responses to such ligands.lipid rafts upon coligation of the BCR and the CD19/
CD21 complex, indicating the formation of a long-lived The CD19/CD21 complex is not an internalizing recep-
tor, and the BCR coligated to the CD19/CD21 complexsignaling complex in the rafts.
The effect of the CD19/CD21 complex on the resi- is retained in the lipid rafts for a long period and fails
to be internalized efficiently. In this regard, the CD19/dency and signaling of the BCR in rafts does not require
coligation of the two. The independent cross-linking of CD21 complex functions as a molecular tether for the
BCR. Indeed, the surface retention of the BCR requiresthe BCR and the CD19/CD21 complex results in in-
creased residency and signaling of the BCR from the the coligation of the BCR and the CD19/CD21 complex
by a complement-tagged antigen and is not observedrafts, although the duration of the effect is not as pro-
longed as with coligation. The CD19/CD21 complex that when the BCR and the CD19/CD21 complex indepen-
dently bind antigen and complement, respectively. Theenters the rafts following complement binding is phos-
phorylated and initiates signal cascades, which presum- physical tethering of the BCR in the lipid rafts when
coligated to the CD19/CD21 complex may contribute toably include the amplification of Lyn activity (Fujimoto
et al., 2000). Thus, the rafts containing the activated the more potent effect of coligation versus independent
cross-linking on BCR raft residency and signaling. ForCD19/CD21 complex would then be more active signal-
ing platforms for the BCR. In this regard, complement- the BCR, internalization is best documented as an im-
portant mechanism for targeting antigen to the peptide-tagged antigens may have an adjuvant-like effect on B
cell activation. In addition, the CD19/CD21 complex that loading compartment (Song et al., 1995; Cheng et al.,
1999). But, in general, for many signaling receptors, in-translocates into lipid rafts may provide an independent
signaling function. The CD19/CD21 complex may have ternalization plays a key role in downregulation of signal-
ing (Krudewig et al., 2000; Trejo et al., 2000; Verdier et al.,ligands other than complement, as suggested by Fearon
and Carroll (2000), and the ability of the CD19/CD21 2000). The relationship between BCR-antigen targeting
and receptor downregulation and the mechanisms bycomplex to translocate into lipid rafts upon cross-linking
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Figure 7. The Internalization of the BCR fol-
lowing Binding of Complement-Tagged An-
tigens
The internalization of the BCR following liga-
tion or coligation with the CD19/CD21 com-
plex was analyzed. CH27 cells were incu-
bated with [125I]Fab anti-Ig at 48C to label the
BCR in the presence or absence of PC-HEL;
to cross-link the BCR or PC-HEL-C3d; to co-
ligate the BCR and the CD19/CD21 complex
(Top panel), PC-HEL, and HEL-C3d; and to
independently cross-link the BCR and the
CD19/CD21 complex (Bottom panel). Anti-
HEL-Tg splenic B cells were incubated with
[125I]Fab anti-Ig at 48C to label the BCR in the
presence or absence of HEL; to ligate the
BCR or HEL-C3d; and to coligate the BCR
and the CD19/CD21 complex (Middle panel).
The cells were washed and warmed to 378C
for varying lengths of time. At the end of each
time point, the radioactivity inside the cells (in-
ternal) and in the fraction released into the su-
pernatant, which was TCA soluble (released
TCA soluble), was measured.
which the CD19/CD21 influences these is not known at response to an extremely strong signal, such as that
provided by complement-tagged antigens.present. The BCR has been shown to be internalized
directly from the lipid rafts when transporting antigen The results presented here show that both CD19 and
CD21 translocate into lipid rafts following binding ofto the class II compartments for processing (Cheng et
al., 1999). The observation that independent cross-link- CD21 to C3d-containing antigens, indicating that CD19
and CD21 function as a complex on the B cell surface.ing of the BCR and the CD19/CD21 complex does not
affect internalization suggests that CD19/CD21 func- Moreover, binding of C3d-containing antigens to CD21
results in the near complete translocation of CD19 intotions to sequester the BCR from the internalization ap-
paratus, resulting in the establishment of a stable, long- rafts. CD19 is generally present in excess of CD21 on
the cell surface. For the CH27 cells described here, flowlived signaling complex within the lipid rafts.
The results presented here suggest that the coligation cytometry analyses indicate that CD19 is present in
2-fold greater concentration as compared to CD21.of the CD19/CD21 complex and the BCR results in a
transient destabilization of the BCR in the rafts. We Thus, the stoichiometry of CD19 and CD21 in complexes
on the cell surface, at least following coligation, may beobserved that a larger fraction of Iga is retained in rafts
30 min after coligation to CD19/CD21, as compared to greater than one to one. The results presented here
also indicate that the BCR and the CD19/CD21 complexIg. A previous report by Vilen et al. (1999) indicated that
BCR cross-linking leads to destabilization of the BCR, behave independently in terms of translocation into the
lipid rafts. Earlier studies suggested that the BCR andas evidenced by the inability to coimmunoprecipitate Ig
and Iga/Igb. These authors suggested that destabiliza- CD19 may be constitutively associated, as evidenced
by the ability to coimmunoprecipitate or cocap the BCRtion may have a physiological function in promoting a
transitory period of receptor desensitization during B and the CD19/CD21 complex (Pesando et al., 1989; Car-
ter et al., 1997). However, functional studies indicate thatcell–T cell interactions. The results presented here sug-
gest that such destabilization occurs in lipid rafts in the absence of CD19 does not affect B cell responses to
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kinase and Vav were purchased from Santa Cruz BiotechnologyT cell–independent antigens that do not coligate the
(Santa Cruz, CA). Rat mAb specific for CD45R/B220, rat IgG2a, andBCR and CD19 (Engel et al., 1995; Rickert et al., 1995).
rat IgG2b and FITC-conjugated goat (secondary) antibodies specificThe results presented here are consistent with the func-
for rat IgG2b were purchased from PharMingen (San Diego, CA).
tional studies and indicate that CD19 is not associated Rabbit polyclonal IgG specific for actin was purchased from Sigma
with the BCR constitutively. Chemical Co. Rabbit polyclonal antibodies specific for mouse Iga
were generated and characterized in this laboratory (Song et al.,In summary, the observations presented here, that the
1995). The phosphotyrosine-specific recombinant mAb RC20H wasCD19/CD21 complex stabilized the BCR in the plasma
purchased from Transduction Laboratories (Lexington, KY). HRP-membrane lipid rafts and blocked internalization of the
conjugated cholera toxin B subunit (CTB) and methyl-b-cyclodextrinBCR, suggest an important mechanism by which the
(MCD) were obtained from Sigma Chemical Co. ImmunoPure Immo-
CD19/CD21 complex may function to augment BCR sig- bilized Streptavidin (Streptavidin-agarose) was purchased from
naling. Pierce Chemical Co. (Rockford, IL). HRP-conjugated streptavidin
was purchased from Amersham Life Sciences (Arlington Heights, IL).
The OPT EIA Mouse IL-2 ELISA Kit was purchased from PharMingen.
Experimental Procedures
Isolation of Lipid Rafts
Mice Cell Lines, Antigens, and Antibodies Lipid rafts were isolated using procedures previously described
Male MD4 H chain transgenic mice (H-2b) hemizygous for the HyHEL (Cheng et al., 1999).
10 H and L chain genes encoding the anti-HEL-specific BCR (Good-
now et al., 1988) and bred to female CBA/J (H-2k) mice were pur-
Surface Biotinylation
chased from Jackson Laboratories (Bar Harbor, ME). F1 mice (H-2b 3
CH27 cells were surface biotinylated using sulfo-N-hydroxysuccini-
H-2k), referred to here as anti-HEL Tg, expressing the HEL-specific
mide long-chain biotin (Pierce Chemical Co.) as previously de-
BCR transgenes were identified by PCR analysis for the HEL-Ig
scribed (Cheng et al., 1999).
sequences. The mouse B cell lymphoma CH27 (H-2k, IgM1,
FcgRIIB12) was maintained in DME supplemented with 15% FCS
Measurement of BCR Internalization(15% CM). The Sf9 insect cell line, used for the expression of HEL-
Goat Fab anti-Ig ([125I]Fab anti-Ig) was iodinated using the iodineC3d, was cultured at 258C in Grace’s insect medium (GIBCO–BRL,
monochloride method, as described (Goldstein et al., 1983), to aGrand Island, NY) supplemented with 10% FCS and antibiotics.
specific activity of 0.5–1.0 3 107 cpm/mg. Unlabeled Fab anti-IgHEL was purchased from Sigma Chemical Co. (St. Louis, MO).
competed with [125I]Fab anti-Ig for binding to the cell surface, indicat-The HEL-C3d DNA construct pCMV.C3d3, which encodes amino
ing that iodination did not affect the binding properties of radio-acids 1–129 of HEL fused to three copies encoding amino acids
labeled antibodies. To measure internalization of surface Ig, CH271024–1320 of the C3d region of the complement component C3
cells (6 3 107) were incubated at 48C for 1 hr with 1 mg [125I]Fab anti-(kindly provided by Dr. D. Fearon, Cambridge University), was cloned
Ig in the absence or presence of 10 mg/ml of the antigens PC-HEL,into a baculovirus vector and expressed in Sf9 insect cells. The
PC-HEL-C3d, or PC-HEL and HEL-C3d. To measure internalizationfusion cassette containing one copy of HEL and three tandemly
in nontransformed lymphocytes, splenic B cells (2.4 3 108) fromarranged copies of C3d was linked to the a chain sequence of
anti-HEL Tg mice were incubated at 48C for 1 hr with 1 mg [125 I]Fabtubulin at the 39 end. The HEL-C3d protein secreted into the culture
anti-Ig in the absence or presence of 10 mg/ml of the antigens HELsupernatant was purified by affinity chromatography on a tubulin-
or HEL-C3d. Cells were washed four times in DME containing 10specific antibody (YL1/2) column, utilizing the C-terminal tubulin
mg/ml BSA, resuspended at 5 3 106 cells/ml, and incubated at 378Csequence of the construct. In brief, the clarified insect cell superna-
for varying lengths of time. The radioactivity released from the cells,tant containing HEL-C3d was passed over a YL1/2-Sepharose 4B
on the cell surface and internalized by cells, was measured as pre-column. The column was washed in 50 mM Tris (pH 7.5), 150 mM
viously described (Song et al., 1995). In brief, following incubation,NaCl, and 0.1 mM EDTA (buffer 1), followed by washes in buffer 2,
cells were pelleted and the supernatants collected. The radioactivityconsisting of buffer 1 with 0.2% NP-40. The column was washed
in the supernatant represented the released fraction. The cell pelletsagain in buffer 1, and bound HEL-C3d was eluted using 50 mM
were resuspended in a low-pH solution (20 mM HCl and 150 mMtriethylamine (pH 11.5), 150 mM NaCl, and 0.1 mM EDTA. Fractions
NaCl) at 48C for 15 min to strip 125I-labeled antibodies from the cellwere pooled, concentrated, and loaded onto a HR-300 (Pharmacia,
surface, and the radioactivity released was taken as the surfacePiscataway, NJ) sizing column. Pooled fractions were dialyzed
fraction. The radioactivity associated with cells after the acid strip-against PBS and protein concentration determined relative to a HEL
ping was taken as the internal fraction. Finally, the released fractionsstandard using the NanoOrange Protein Quantitation Kit purchased
were treated with 10% TCA to precipitate intact protein, and radio-from Molecular Probes (Eugene, OR). Phosphorylcholine (PC) was
activity in the precipitate and in the soluble fractions was measured.coupled to HEL (PC-HEL) and to HEL-C3d (PC-HEL-C3d), using
diazo-phosphatidylcholine (DPPC), as previously described (Shaw
Immunoprecipitation and Immunoblottinget al., 1990). Human recombinant C3dg was kindly provided by
Immunoprecipitation of biotinylated cell lysates using mAb specificDr. D. Isenman (University of Toronto, Canada). The antigens were
for CD19, streptavidin-agarose, or isotype control rat IgG2a wasanalyzed for purity by SDS-PAGE and immunoblot analysis using
done as detailed previously (Cheng et al., 1999). Immunoblottingthe HEL-specific mAb HyHEL 10 and HRP-conjugated goat anti-
of the polyvinylidene difluoride (PVDF) membranes (Millipore Co.,mouse IgG (H1L) secondary antibodies for detection.
Bedford, MA), using mAb specific for CD21, polyclonal Abs specificThe rat hybridoma 1D3, producing an IgG2a mAb specific for
for BCR, HRP-conjugated RC20H to detect tyrosine-phosphorylatedthe extracellular domain of mouse CD19, was purchased from the
proteins, or HRP-conjugated streptavidin to detect CD19, followedAmerican Tissue Type Culture Collection (Rockville, MD) and main-
by incubation with secondary HRP-conjugated goat Abs specifictained in this laboratory. The rat hybridoma 7E9, producing an IgG2a
for the primary Abs, was done as previously described (Cheng et al.,mAb specific for mouse CD21/CD35, was generously provided by
1999). Blots were developed using enhanced chemiluminescenceDr. M. Holers (University of Colorado Health Sciences Center, Den-
(ECL, Amersham-Pharmacia Biotech, Buckinghamshire, England)ver, CO). The rat hybridoma YL1/2, secreting an IgG mAb specific
and all films quantified by densitometry.for mouse tubulin, was provided by Dr. D. Fearon. The mouse hybrid-
oma HyHEL 10, generated and characterized by Smith-Gill et al.
Received May 26, 2000; revised January 24, 2001.(1982), is specific for HEL sequences. The mAbs produced by the
above cell lines were purified from culture supernatants by protein
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